Guillaume Pataud, MD
a:2:{i:0;s:121:"Optimisation Thérapeutique en Neuropsychopharmacologie, UMR-S1144 Team 1, Inserm, Université Paris Cité, Paris, France";i:1;s:135:"APHP, Hôpital Lariboisière – Fernand Widal, Département Universitaire de Psychiatrie et de Médecine Addictologique, Paris, France";}
Original Research
Bright Light Therapy in the Morning or Midday for Nonseasonal Depression in Bipolar Disorder
June 23, 2025
Bright light therapy is well tolerated in bipolar disorder, starting at 45 minutes/day, with only 6% of patients experiencing a hypomanic switch and 13% experiencing subsyndromic symptoms, which resolved...